Wrap Technologies, Inc. (WRAP) Company Overview

What does Wrap Technologies do?

Wrap Technologies, Inc. is a Nasdaq Capital Market public-safety technology company focused on early intervention before an encounter escalates to pain-based or higher-force options. It reports as one operating segment, while its portfolio spans restraint hardware, consumables, immersive training, body-worn video, evidence management, and emerging drone systems. Its 2025 Form 10-K is the best foundation for understanding that expanding scope.

Which products form the platform?

Who buys the products, and where?

Buyers include police departments, corrections agencies, federal organizations, international ministries, distributors, and training programs. Agencies typically test equipment, train users, secure budgets, and begin with limited deployments. Sales cycles are therefore uneven, but successful pilots can produce cassette reorders, training revenue, and department-wide expansion. Approximately 45.0% of FY2025 gross revenue came from EMEA and APAC. The portfolio is summarized on its official investor-relations profile.

How does Wrap make money, and which revenue stream matters most?

Wrap reports product sales and technology-enabled services. Products include BolaWrap devices, cassettes, accessories, cameras, and related hardware; services include virtual-reality training, cloud-related offerings, and contracted support. Product sales remained larger in FY2025, while services grew faster. The objective is an installed-base model in which consumables, software, evidence management, and training deepen each agency relationship.

Why do consumables and subscriptions matter?

Recurring revenue could smooth government hardware orders and improve customer lifetime value. Yet services and consumables do not cover the corporate cost base, and the service line fell in Q1 2026 after certain managed-service arrangements were wound down. The recurring-revenue ambition still exceeds the evidence.

How concentrated is the commercial model?

What does the latest reported period show?

The quarter ended March 31, 2026 showed stronger product demand, but operating costs remained several times larger than sales. The Q1 2026 earnings release emphasized bookings, product growth, and lower operating cash use; the accompanying Form 10-Q provides the necessary accounting detail.

Revenue growth improved, but the loss widened

Bookings were strong, but they are not revenue

Operating cash use improved to $1.246M from $3.069M as receivables were collected and inventory declined. Cash nevertheless rose mainly because financing contributed $5.1M, not because operations became self-funding.

Strategic turning points that reshaped Wrap

Wrap’s history is best read as a sequence of attempts to turn one differentiated device into a broader public-safety platform. Each expansion increases the addressable market, but it also adds execution requirements, capital needs, and competitors.

1. 2016
   The business was co-founded around a non-pain restraint concept, establishing the product philosophy that still differentiates BolaWrap.
2. 2017
   A reverse-merger transaction created the public company and the Wrap Technologies name, making equity markets an important funding channel.
3. 2018
   Initial BolaWrap 100 sales began, moving the idea from development into agency evaluation and field adoption.
4. 2020
   The NSENA acquisition established the foundation for Wrap Reality, adding training as a complementary service rather than relying only on device shipments.
5. 2022
   BolaWrap 150 replaced the prior generation, concentrating product development and consumable demand on the current platform.
6. 2023
   The Intrensic acquisition added body-worn video and digital evidence capabilities, widening the platform but also increasing integration demands.
7. 2025
   Wrap launched WrapVision and WrapTactics, formed Wrap Federal, and accelerated drone and counter-UAS initiatives.
8. 2026
   An ATF classification and the Frenel transaction pushed the strategy toward federally accessible restraint products, sensing, thermal imaging, and a wider WrapShield architecture.

What changed strategically?

What gives Wrap a competitive position in public safety?

Wrap’s differentiation is BolaWrap’s role in the force continuum. It seeks to restrain from a distance without shock, chemical irritant, impact, or projectile-based pain compliance. That may fit behavioral-health calls, corrections, hospitals, schools, and transport sites. Training and documented-use workflows reinforce the hardware.

Where is the moat credible?

Intellectual property, certification, policy integration, and user familiarity can create switching friction, while cassettes benefit from the installed base. These advantages remain developing: small revenue, concentration, and persistent losses show that differentiation has not yet become a self-financing moat.

Which competitors pressure the model?

ATF declassification and WrapShield redefine the growth narrative

In 2026, ATF Ruling 2026-2 classified BolaWrap 150 as an instrument of restraint rather than a firearm under the Gun Control Act or an “any other weapon” under the National Firearms Act. The official ATF ruling page provides the classification. Wrap argues that it removes a significant procurement and distribution barrier, especially in corrections and restricted environments. The ruling does not guarantee orders, but it improves regulatory clarity.

What could the ruling unlock?

The immediate evidence is order flow, not recognized revenue. On July 13, 2026, Wrap announced $1.2M of orders from Brazil and India. The amount is meaningful relative to historical quarterly revenue but remains subject to delivery and revenue recognition. The company announcement should therefore be read as a demand signal, not as a completed earnings result.

How does WrapShield broaden the strategy?

The July 2026 stockholder letter describes WrapShield as an architecture spanning detection, identification, classification, direction, response, and escalation under human control. The concept links sensors and decision support to non-lethal response. In parallel, Wrap invested $2.0M in Frenel, secured an exclusive U.S. and selected NATO distribution license for polarimetric thermal imaging, and accepted commercial milestones over a four-year initial exclusivity period. The July 2026 Form 8-K makes the trade-off visible: a potentially differentiated sensing asset, but a meaningful capital commitment for a company whose Q1 cash balance was $7.264M.

How financially strong is Wrap?

Wrap is liquid near term but not self-sustaining. At March 31, 2026, current assets of $14.474M exceeded current liabilities of $1.908M, while total liabilities were $2.288M. The constraint was operating scale: Q1 SG&A of $5.355M far exceeded gross profit of $0.691M.

Annual context shows the scale gap

Capital allocation depends on equity access

Wrap raised $10.2M in FY2025 financing transactions and $5.1M in Q1 2026 financing and warrant proceeds. The capital funds inventory, sales, development, and investments, but increases the share count. Common shares outstanding rose from 51.733M at December 31, 2025 to 55.507M at March 31, 2026. For valuation work, dilution is not a side issue; it is part of the economic cost of funding the strategy.

Who owns Wrap stock, and why does governance matter?

Wrap has one-vote common stock, but ownership is concentrated. The proxy showed substantial beneficial ownership by CEO and Executive Chairman Scot Cohen through V4 Global and by co-founder Elwood Norris. Beneficial ownership may include exercisable securities and is not identical to outstanding common shares. The 2025 definitive proxy statement is the official source for the table below.

Economic ownership and voting influence

Ownership changed after the proxy date. A May 2026 Schedule 13G reported 4,491,344 shares, or approximately 8.2%, for the Norris Family 1997 Trust, illustrating why current ownership filings should be checked alongside the annual proxy.

What governance signals should investors interpret?

Governance and financing are tightly linked. Concentrated ownership may support strategic continuity, while an expanding equity pool can shift future value from existing holders to new capital providers, employees, and other security holders.

What opportunities and risks should researchers monitor?

Wrap’s opportunity set is larger than its current revenue base, which creates both upside potential and analytical uncertainty. The best research approach is to connect each strategic claim to an observable operating milestone rather than treating announcements as equivalent to commercial success.

Where could growth come from?

Which risks could change the story?

Which KPIs best explain Wrap’s progress?

Revenue alone is insufficient because the business is transitioning across products, geographies, and funding stages. A useful dashboard combines demand, unit economics, cash conversion, and dilution.

How should each KPI be interpreted?

What is the key takeaway for a DCF or case study?

Wrap is not a mature-company DCF. Cash flow is negative, revenue is small, and strategic value depends on milestones not yet visible in earnings. Scenario analysis is more defensible than treating management’s growth target as certain. Key assumptions include bookings conversion, mix, gross margin, expense scaling, working capital, financing, and fully diluted shares.